Premium
Treatment‐specific utility weightings are needed for cost–utility analysis in metastatic melanoma
Author(s) -
Sebaratnam D.F.,
Anforth R.,
FernándezPeñas P.
Publication year - 2016
Publication title -
british journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.304
H-Index - 179
eISSN - 1365-2133
pISSN - 0007-0963
DOI - 10.1111/bjd.14264
Subject(s) - metastatic melanoma , medicine , melanoma , cost–utility analysis , intensive care medicine , oncology , cost effectiveness , risk analysis (engineering) , cancer research